SCHEMBL27686738

SCHEMBL27686738

CC(C)c1ccc(-n2ccn(Cc3ccncc3)c2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 2/20 0.40
▸ CA9 Q16790 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ MGLL Q99685 1/20 0.36
▸ ITGB1 P05556 1/20 0.36
▸ ITGA4 P13612 1/20 0.36
▸ FLT1 P17948 1/20 0.35
▸ KDR P35968 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ PPARD Q03181 1/20 0.35
▸ PPARA Q07869 1/20 0.35
▸ HDAC3 O15379 1/20 0.34
▸ HDAC4 P56524 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC7 Q8WUI4 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ HDAC10 Q969S8 1/20 0.34
▸ HDAC11 Q96DB2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25669483 0.76 MGLL (0.41) NOTUMALDH1A1MGLLMEN1NPC1
SCHEMBL27431461 0.72 PKM (0.43) HTTALDH1A1PKMHDAC3HDAC4
SCHEMBL21201591 0.69 NPBWR1 (0.40) NOTUMHTTALDH1A1SMN1; SMN2MAPT
SCHEMBL20644587 0.68 MGLL (0.46) NOTUMALDH1A1MGLLMEN1NPC1
SCHEMBL20644375 0.68 MAPT (0.39) CA9HTTALDH1A1SMN1; SMN2MAPT
SCHEMBL19501369 0.66 KMT2A (0.43) NOTUMPKMMEN1NPC1RAB9A
SCHEMBL27524823 0.65 ADORA2B (0.36) HDAC8
SCHEMBL20644471 0.64 SMN1; SMN2 (0.36) HTTALDH1A1MEN1RAB9AKMT2A
SCHEMBL10022388 0.63 LMNA (0.65) ALDH1A1KMT2A
SCHEMBL17540820 0.63 POLB (0.54) HTTALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101010314-A Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors AVENTIS PHARMA SA (FR) 2007-08-01 — — CN disclosed
Send feedback